Strattera and Drug level below therapeutic - a phase IV clinical study of FDA data

Summary:

Drug level below therapeutic is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are male, 2-9 old, have been taking the drug for 1 - 6 months also take Abilify, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Drug level below therapeutic when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Drug level below therapeutic?

Drug level below therapeutic is found to be associated with 410 drugs and 449 conditions by eHealthMe. Check the latest studies of Drug level below therapeutic.

On Jul, 19, 2026

27,428 people reported to have side effects when taking Strattera.
Among them, 11 people (0.04%) have Drug level below therapeutic.

Could Strattera cause Drug level below therapeutic?

Among these 11 people:

How long have people been on Strattera when they have Drug level below therapeutic? *

What is the gender of people who have Drug level below therapeutic when taking Strattera? *

female: 40 %
male: 60 %

What is the age of people who have Drug level below therapeutic when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Drug level below therapeutic? *

Weight Increased: 4 people, 36.36%
Stress And Anxiety: 4 people, 36.36%
Feeling Jittery: 4 people, 36.36%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 36.36%
Bipolar Disorder (mood disorder): 3 people, 27.27%
Affect Lability (emotional incontinence): 3 people, 27.27%
Agitation (state of anxiety or nervous excitement): 3 people, 27.27%
Thinking Abnormal: 2 people, 18.18%
Food Poisoning (poison in food): 2 people, 18.18%
Hepatic Necrosis (large portions of liver die off due to severe liver disease): 2 people, 18.18%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 4 people, 36.36%
Affective Disorder (mental disorder): 3 people, 27.27%
Mood Swings (an extreme or rapid change in mood): 2 people, 18.18%
Aggression: 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Drug level below therapeutic?

- Check whether Drug level below therapeutic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,323 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug level below therapeutic:

Drug level below therapeutic (410 drugs)

Browse all the conditions that are associated with Drug level below therapeutic:

Drug level below therapeutic (449 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.